You are here

allergy shots

Allergy Therapeutics suffers phase 3 birch allergy jab trial failure

Pharmaforum

Mon, 03/18/19 - 10:33 am

Allergy Therapeutics

clinical trials

Circassia Raises $333.5 Million in IPO for Allergy Shot

Bloomberg

Thu, 03/13/14 - 08:47 am